Colin Reisner

Colin Reisner

Chief Executive Officer at Pearl Therapeutics, Inc.

Health Technology
Consumer Services
Commercial Services

Profile

Colin Reisner is currently the Chief Executive Officer at Pearl Therapeutics, Inc. and a Member at the American Thoracic Society, Inc. Previously, he held positions as the Executive Director-Global Respiratory Development at Novartis Corp., Senior Director-Respiratory Division at GlaxoSmithKline, Inc., Head-Clinical Respiratory at AstraZeneca PLC, Assistant Consulting Professor at Duke University and Yale University, and Principal at Boehringer Ingelheim Corp.
He completed his undergraduate degree at the University of the Witwatersrand.

Colin Reisner active positions

CompaniesPositionStart
Chief Executive Officer 2007-09-30
Corporate Officer/Principal -
All active positions of Colin Reisner

Former positions of Colin Reisner

CompaniesPositionEnd
ASTRAZENECA PLC Corporate Officer/Principal -
Corporate Officer/Principal -
Yale University Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Colin Reisner's experience

Training of Colin Reisner

University of the Witwatersrand Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Colin Reisner's experience

Connections

37

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ASTRAZENECA PLC

Health Technology

Private companies5

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

See company connections